Insiders · Profile

Kelly Paul Edward

Chief Operating Officer at RELMADA THERAPEUTICS. Filing since 14 Dec 2015. CIK 0001658544

Company
Date
Role
Action
Shares
Amount
Of holding
5 Nov 2025
Chief Operating Officer
Bought
90,000
$198.00K
21.8%
16 May 2025
Chief Operating Officer
Bought
200,000
$86.06K
94.2%
9 Sep 2024
Director
Bought
25,000
$64.75K
13.3%
4 Apr 2022
Director
Sold, plan not stated
10,000
$300.40K
5.1%
9 Mar 2021
Director
Sold, plan not stated
5,000
$178.55K
2.9%
24 Feb 2021
Director
Sold, plan not stated
5,000
$170.93K
2.9%
9 Feb 2021
Director
Sold, plan not stated
2,069
$73.00K
1.3%
8 Feb 2021
Director
Sold, plan not stated
1,500
$52.56K
0.9%
2 Feb 2021
Director
Sold, plan not stated
2,315
$81.12K
1.4%
1 Feb 2021
Director
Sold, plan not stated
31
$1.09K
0.0%
27 Jan 2021
Director
Sold, plan not stated
5,000
$162.32K
3.3%
26 Jan 2021
Director
Sold, plan not stated
685
$24.08K
0.5%
25 Jan 2021
Director
Sold, plan not stated
1,300
$45.85K
0.9%
22 Jan 2021
Director
Sold, plan not stated
2,100
$6.39M
1.4%
18 Oct 2019
Director
Bought
5,000
$95.69K
4.1%
14 May 2019
Director
Bought
100,000
$150.00K
25.7%
11 Dec 2018
Director
Bought
5,000
$6.07K
1.3%
12 Oct 2018
Director
Bought
150,000
$135.00K
×15
14 Dec 2015
Director
Bought
10,000
$29.06K
opened
19 decisions on file.